Patients who respond to panic-focused psychotherapy appear to maintain their improvements following treatment termination.
Therapeutic response to antidepressants is highly variable, which may be partially due to associated side effects.
Preemies may possess elevated levels of characteristics that put them at risk for peer victimization, including more anxiety and depression.
New tools and therapies are available for the approximately 6 million US adults with panic disorder.
Patients with sleep apnea appear to be predisposed to panic disorder, based on a study conducted in Taiwan.
A new spectrum disorder, known by the acronym ALPIM, associates panic disorder with several physical illnesses.
Meta-analysis finds that 45% of patients with bipolar disorder will develop an anxiety disorder in their lifetime.
Losing a loved one leads to an elevated risk of developing depression, panic disorder and PTSD.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Health and Social Factors Predict Changes in Depressive Symptoms in Women
- ASD Risk on Offspring With Prenatal Use of Medication Affecting Neurotransmitter System
- Effects of Impaired Glucose Metabolism on Lithium and Other Mood Stabilizers
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Heart Rate Variability Predicts Treatment Response in Anxious Depression
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Can Examining Marginalization Identify Gaps in Medical or Nutritional Care?
- Efficacy, Safety of Long-Term Ketamine Administration Still In Question
- Vulnerability to Psychosocial Disability in Psychosis
- Behavioral Health Screening Advocated for Teens With Epilepsy
- KCNQ Channel Potentiator Ezogabine Delivers Promising Results in Major Depressive Disorder